StockOtters
StockOttersSupply Chain Map
Chugai Pharmaceutical Co., Ltd. logo

Chugai Pharmaceutical Co., Ltd.

4519.T

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
7,843
Cost of Revenue
2,277
Gross Profit
5,566
Gross Margin
71.0%
Operating Income
3,644
Operating Margin
46.5%
Net Income
2,595
Net Margin
33.1%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
3,851
EBITDA Margin
49.1%

2023

12/31/2023

Revenue
7,446
Cost of Revenue
2,803
Gross Profit
4,643
Gross Margin
62.4%
Operating Income
2,785
Operating Margin
37.4%
Net Income
2,181
Net Margin
29.3%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
3,187
EBITDA Margin
42.8%

2022

12/31/2022

Revenue
8,442
Cost of Revenue
3,195
Gross Profit
5,247
Gross Margin
62.2%
Operating Income
3,577
Operating Margin
42.4%
Net Income
2,509
Net Margin
29.7%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
3,770
EBITDA Margin
44.7%

2021

12/31/2021

Revenue
6,698
Cost of Revenue
2,275
Gross Profit
4,424
Gross Margin
66.0%
Operating Income
2,906
Operating Margin
43.4%
Net Income
2,030
Net Margin
30.3%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
3,017
EBITDA Margin
45.0%

2020

12/31/2020

Revenue
5,273
Cost of Revenue
1,844
Gross Profit
3,429
Gross Margin
65.0%
Operating Income
2,056
Operating Margin
39.0%
Net Income
1,439
Net Margin
27.3%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
2,202
EBITDA Margin
41.8%